Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT
Shah Gaurav sold 2,216 Rocket Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 18, 2026 · Filed Nov 20, 2026
On Nov 18, 2026, Shah Gaurav (CEO) sold 2,216 Rocket Pharmaceuticals, Inc. shares at US$2.18 for US$4,826, leaving 1,051,358 shares. Filed Nov 20, 2026 (Form 4).
- Sold
- 2,216 shares
- Price
- US$2.18
- Value
- US$4,826
- Holding after
- 1,051,358 shares
- Trading plan
- No
- Role
- CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | Sale | 2,216 | US$2.18 | 1,051,358 | Direct |
Source
Download original · View original at SEC
Related
- Rocket Pharmaceuticals, Inc.
- Shah Gaurav
- Rocket Pharmaceuticals, Inc. shareholders
- Form 4 · Shah Gaurav · Nov 17, 2026
- Form 4 · Shah Gaurav · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 17, 2026
- Form 4 · Shah Gaurav · May 26, 2026
- Form 4 · Shah Gaurav · May 21, 2026
- Form 4 · Wilson Martin · Nov 20, 2026
- Form 4 · Wilson Martin · Nov 17, 2026
- Form 4 · Chaudhuri Sarbani · Nov 12, 2026
- Form 4 · Wilson Martin · Nov 9, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Oct 30, 2026